J. L. Puche

67 Phase II activity of gemcitabine + cisplatin in advanced non-small cell lung cancer (NSCLC)

J. Feliu, M. González-Barón, J. Dorta, 1997 .

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

A. Carrato, R. Salazar, C. García-Girón, 2021, Drugs & Aging.

Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection

M. Delgado-Rodríguez, J. Lorente, F. G. Ortega, 2016, PloS one.

Significance of EGFR Expression in Circulating Tumor Cells.

J. Lorente, I. Robles-Fernandez, A. Rodríguez-Martínez, 2017, Advances in experimental medicine and biology.

Biodynamic Phenotypic and Epigenetics Changes of Circulating Tumor Cells: Their Application in Cancer Prognosis and Treatment

J. Lorente, F. G. Ortega, M. Álvarez-Cubero, 2015 .

Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers†

M. Delgado-Rodríguez, J. Lorente, M. Serrano, 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.

J. Lorente, I. Robles-Fernandez, A. Rodríguez-Martínez, 2017, Methods in molecular biology.

Relapse of unusual localization of classic seminoma with post-chemotherapy transformation

J. Aparicio, J. L. Puche, J. Jurado, 2014 .

Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.

J. Lorente, I. Robles-Fernandez, M. Serrano, 2017, Methods in molecular biology.